Previous therapies for CML consisted of hemopoietic stem cells transplantation (HSCT), interferon alpha (IFN-α)-based treatment, and simple cell reduction treatment with hydroxyurea (HU). This evidence concerns the gene IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive.